Evidence map›Paper›PMID 38075666›Full record

ArticleChemical science2023

Use of pyridazinediones for tuneable and reversible covalent cysteine modification applied to peptides, proteins and hydrogels.

Léa N C Rochet, Calise Bahou, Jonathan P Wojciechowski, Ilias Koutsopetras, Phyllida Britton, Richard J Spears, Ioanna A Thanasi, Baihao Shao, Lisha Zhong, Dejan-Krešimir Bučar and 5 more

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Léa N C RochetDepartment of Chemistry, University College London 20 Gordon Street London WC1H 0AJ UK v.chudasama@ucl.ac.uk j.r.baker@ucl.ac.uk.
Calise BahouDepartment of Chemistry, University College London 20 Gordon Street London WC1H 0AJ UK v.chudasama@ucl.ac.uk j.r.baker@ucl.ac.uk.
Jonathan P WojciechowskiDepartment of Materials, Department of Bioengineering, Institute of Biomedical Engineering, Imperial College London London SW7 2AZ UK.ORCID https://orcid.org/0000-0002-6272-515X
Ilias KoutsopetrasBio-Functional Chemistry (UMR 7199), Institut du Médicament de Strasbourg, University of Strasbourg 74 Route du Rhin 67400 Illkirch-Graffenstaden France.ORCID https://orcid.org/0000-0002-9078-6099
Phyllida BrittonDepartment of Chemistry, University College London 20 Gordon Street London WC1H 0AJ UK v.chudasama@ucl.ac.uk j.r.baker@ucl.ac.uk.
Richard J SpearsDepartment of Chemistry, University College London 20 Gordon Street London WC1H 0AJ UK v.chudasama@ucl.ac.uk j.r.baker@ucl.ac.uk.ORCID https://orcid.org/0000-0001-9846-8637
Ioanna A ThanasiDepartment of Chemistry, University College London 20 Gordon Street London WC1H 0AJ UK v.chudasama@ucl.ac.uk j.r.baker@ucl.ac.uk.
Baihao ShaoDepartment of Materials, Department of Bioengineering, Institute of Biomedical Engineering, Imperial College London London SW7 2AZ UK.
Lisha ZhongDepartment of Materials, Department of Bioengineering, Institute of Biomedical Engineering, Imperial College London London SW7 2AZ UK.
Dejan-Krešimir BučarDepartment of Chemistry, University College London 20 Gordon Street London WC1H 0AJ UK v.chudasama@ucl.ac.uk j.r.baker@ucl.ac.uk.ORCID https://orcid.org/0000-0001-6393-276X
Abil E AlievDepartment of Chemistry, University College London 20 Gordon Street London WC1H 0AJ UK v.chudasama@ucl.ac.uk j.r.baker@ucl.ac.uk.
Michael J PorterDepartment of Chemistry, University College London 20 Gordon Street London WC1H 0AJ UK v.chudasama@ucl.ac.uk j.r.baker@ucl.ac.uk.ORCID https://orcid.org/0000-0002-0376-5434
Molly M StevensDepartment of Materials, Department of Bioengineering, Institute of Biomedical Engineering, Imperial College London London SW7 2AZ UK.ORCID https://orcid.org/0000-0002-7335-266X
James R BakerDepartment of Chemistry, University College London 20 Gordon Street London WC1H 0AJ UK v.chudasama@ucl.ac.uk j.r.baker@ucl.ac.uk.ORCID https://orcid.org/0000-0002-7223-2279
Vijay ChudasamaDepartment of Chemistry, University College London 20 Gordon Street London WC1H 0AJ UK v.chudasama@ucl.ac.uk j.r.baker@ucl.ac.uk.ORCID https://orcid.org/0000-0002-8876-3285
University College London · GBImperial College London · GBUniversité de Strasbourg · FR

Funding

Medical Research Council MR/R015651/1
6 · The paper itself

Abstract

Reversible cysteine modification has been found to be a useful tool for a plethora of applications such as selective enzymatic inhibition, activity-based protein profiling and/or cargo release from a protein or a material. However, only a limited number of reagents display reliable dynamic/reversible thiol modification and, in most cases, many of these reagents suffer from issues of stability, a lack of modularity and/or poor rate tunability. In this work, we demonstrate the potential of pyridazinediones as novel reversible and tuneable covalent cysteine modifiers. We show that the electrophilicity of pyridazinediones correlates to the rates of the Michael addition and retro-Michael deconjugation reactions, demonstrating that pyridazinediones provide an enticing platform for readily tuneable and reversible thiol addition/release. We explore the regioselectivity of the novel reaction and unveil the reason for the fundamental increased reactivity of aryl bearing pyridazinediones by using DFT calculations and corroborating findings with SCXRD. We also applied this fundamental discovery to making more rapid disulfide rebridging agents in related work. We finally provide the groundwork for potential applications in various areas with exemplification using readily functionalised "clickable" pyridazinediones on clinically relevant cysteine and disulfide conjugated proteins, as well as on a hydrogel material.

Identifiers

PMID38075666
PMCPMC10699563
OpenAlexW4388144461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.